Arlington Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-274
| Closed | -$16.7K | – | 707 |
|
|
2025
Q1 | $16.7K | Sell |
274
-117
| -30% | -$7.14K | ﹤0.01% | 474 |
|
|
2024
Q4 | $22.1K | Buy |
391
+117
| +43% | +$6.62K | ﹤0.01% | 417 |
|
|
2024
Q3 | $14.2K | Sell |
274
-1,582
| -85% | -$81.9K | ﹤0.01% | 427 |
|
|
2024
Q2 | $77.1K | Buy |
1,856
+900
| +94% | +$37.4K | 0.02% | 285 |
|
|
2024
Q1 | $51.8K | Sell |
956
-100
| -9% | -$5.42K | 0.01% | 282 |
|
|
2023
Q4 | $54.2K | Buy |
+1,056
| New | +$54.2K | 0.02% | 279 |
|